1. Home
  2. LXU vs CAPR Comparison

LXU vs CAPR Comparison

Compare LXU & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXU
  • CAPR
  • Stock Information
  • Founded
  • LXU 1968
  • CAPR 2005
  • Country
  • LXU United States
  • CAPR United States
  • Employees
  • LXU N/A
  • CAPR N/A
  • Industry
  • LXU Major Chemicals
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LXU Industrials
  • CAPR Health Care
  • Exchange
  • LXU Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • LXU 552.9M
  • CAPR 578.4M
  • IPO Year
  • LXU 1969
  • CAPR N/A
  • Fundamental
  • Price
  • LXU $9.07
  • CAPR $13.70
  • Analyst Decision
  • LXU Strong Buy
  • CAPR Strong Buy
  • Analyst Count
  • LXU 4
  • CAPR 7
  • Target Price
  • LXU $10.75
  • CAPR $39.29
  • AVG Volume (30 Days)
  • LXU 364.6K
  • CAPR 1.1M
  • Earning Date
  • LXU 03-04-2025
  • CAPR 02-27-2025
  • Dividend Yield
  • LXU N/A
  • CAPR N/A
  • EPS Growth
  • LXU N/A
  • CAPR N/A
  • EPS
  • LXU N/A
  • CAPR N/A
  • Revenue
  • LXU $520,107,000.00
  • CAPR $23,228,045.00
  • Revenue This Year
  • LXU N/A
  • CAPR N/A
  • Revenue Next Year
  • LXU $4.33
  • CAPR $74.85
  • P/E Ratio
  • LXU N/A
  • CAPR N/A
  • Revenue Growth
  • LXU N/A
  • CAPR 65.33
  • 52 Week Low
  • LXU $6.74
  • CAPR $3.52
  • 52 Week High
  • LXU $10.40
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • LXU 65.40
  • CAPR 45.79
  • Support Level
  • LXU $9.00
  • CAPR $12.31
  • Resistance Level
  • LXU $9.39
  • CAPR $16.17
  • Average True Range (ATR)
  • LXU 0.32
  • CAPR 0.83
  • MACD
  • LXU 0.21
  • CAPR 0.07
  • Stochastic Oscillator
  • LXU 85.59
  • CAPR 36.01

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural, industrial, and mining markets. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.

Share on Social Networks: